noice, page-27

i have done my research and i m also in favour of this company but not increasing my holding as the problem with all this company is preserving cash and expanding at same time but when is there cash flow problem on the other side it is hard to sell ,look at vcr,pxs,acl,bta csl all having problem to market as government body are more intrested in the financial sector then biotech,unless financial sector improves then funding for others become available.i rate this as longterm buy and d ur research